2-Chloro-N-(2-(2-chlorobenzoyl)-4-nitrophenyl)acetamide, 95.0%, 100g

5-(4-Fluorophenyl)-2H-pyrazol-3-ylamine, 95.0%, 1g

Methyl 5-bromonicotinoylacetate, 95.0%, 10g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline, 98+%, 1g

Diéthanolamine, min 99 %, pour la synthèse, 2,5 l, emballage plastique.

Sodium 4-fluorobenzoate, 97.0%, 500g

(4-Bromo-2,6-difluorophenyl)trimethylsilane, 98%, 250mg

O-(2-bromobenzyl)hydroxylamine hydrochloride, 95+%, 5g

(R)-di-tert-butyl 2-((S)-4-amino-5-tert-butoxy-5-oxopentanamido)pentanedioate, 97%, 1g

2-Bromopyrimidin-5-ol, 95.0%, 25g

4-Chloropicolinic acid, 98.0%, 10g

Methyl 2-hydroxy-3-methylbutanoate, 97%, 10g

SRC KINASE INHIBITOR I, 95%, 250mg